The value of Mediastinoscopy in Preoperative Evaluation of Mediastinal Involvement in Non-Small-Cell Lung Cancer Patients with Clinical NO Disease
A. Gürses, A. Turna, M. A. Bedirhan, T. Özalp, C. Kocatürk, A. Demir, M. Özcan, N. Ürer
1Yedikule Hospital for Chest Disease and Thoracic Surgery (Yedikule Gögˇüs Hastalıkları ve Gögˇüs Cerrahisi Egˇitim ve Araştırma Hastanesi), Istanbul, Turkey)
Presented at the 8th European Conference on General Thoracic Surgery, London, 1st - 3rd November, 2000
Background: The efficacy of mediastinal lymph node examination using cervical mediastinoscopy in operable non-small cell lung cancer patients without radiological nodal involvement on computerized tomography (CT) has been elusive. Methods: The value of mediastinoscopy as a staging modality for assessing the mediastinal lymph node status was evaluated in 79 patients with presumed resectable non-small-cell lung cancer (NSCLC) with mediastinal nodes smaller than 1 cm (NO) form the CT scan. Sixty-one patients who did not have nodal involvement at mediastinoscopy and had complete medical records underwent complete resection. Results: Negative predictive value (NPV) of the CT scan according to mediastinoscopy was 92.4 %. Histopathological examination of the surgical specimen showed the NPV of mediastinoscopy to be 93.4 %. Only 4 patients (3 patients with N2, 1 patient with N3 disease) were not correctly staged using CT scanning and mediastinoscopy. According to the pathological examination, the NPV of CT was found to be lower (76.5 %) in patients with adenocarcinoma, but the difference was not statistically significant (p > 0.128) Conclusion: Although the likelihood of surgical-pathological N2 is slightly higher in patients with adenocarcinoma, radiological examination of patients with cNO NSCLC disease can be as accurate as mediastinoscopy in appropriately staging mediastinal lymph node involvement.
1
Liewald F, Grosse S, Storck M. et al .
How useful is positron emission tomography for lymph node staging in non-small-cell lung cancer?.
Thorac Cardiovasc Surg.
2000;
48
93-96
2
Chin R, Keyes J W. et al .
Mediastinal staging of non-small cell lung cancer with positron emission tomography.
Am J Repir Crit Care Med.
1995;
152
2090-2096
5
Suzuki K, Nagai K, Yoshida J. et al .
Clinical predictors of N2 disease in the setting of a negative computed tomographic scan in patients with lung cancer.
J Thorac Cardiovasc Surg.
1999;
117
593-598
6
Daly B D, Mueller J D, Falling L J. et al .
N2 lung cancer: Outcome in patients with false-negative computed tomographic scans of the chest.
J Thorac Cardiovasc Surg.
1993;
105
904-910
7
Khan A, Gersten K C, Garvey J. et al .
Oblique hilar tomography, computed tomography, and mediastinoscopy for prethoracotomy staging of bronchogenic carcinoma.
Radiology.
1985;
156
295-298
8
Backer C L, Shields T W, Lockhart C G. et al .
Selective preoperative evaluation for possible N2 disease hi carcinoma of the lung.
J Thorac Cardiovasc Surg.
1987;
93
337-343
9
Webb W R, Gatsonis C, Zerhouni E A. et al .
CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group.
Radiology.
1991;
178
705-713
10
Rhoads A C, Thomas J H, Hermreck A S. et al .
Comparative studies of computerized tomography and mediastinoscopy for the staging of bronchogenic carcinoma.
Am J Surg.
1986;
152
587-591
17
Gdeedo A, van Schil P, Corthouts B. et al .
Prospective evaluation of computed tomography and mediastinoscopy in mediastinal lymph node staging.
Eur Respir J.
1997;
10
1547-1551
18
Khan A, Khan F A, Garvey J. et al .
Oblique hilar tomography and mediastinoscopy. A correlative prospective study in 100 patients with bronchogenic carcinoma.
Chest.
1984;
86
424-429
20
Little A G, Dehoyos A, Kirgan D M. et al .
Intraoperative lymphatic mapping for non-small cell lung cancer: The sentinel node technique.
J Thorac Cardiovasc Surg.
1999;
117
220-224
